The tasks and responsibilities of peer reviewers are examined as a step towards reaching a consensus on their role in biomedical publishing
Ruairi Mackenzie provides a personal account of attending a “fake” conference run by Conference Series in a recent article for Technology Networks.
A recent preprint sheds light on just how volatile journal impact factors can be.
Does professional medical writing support impact the quality, ethics and timeliness of clinical trial reporting?
Findings of a systematic review show working with professional medical writers positively affects measures of quality, ethics and timeliness.
The MAP newsletter explores an issue faced by medical publication professionals.
Join CBI to discuss challenges, innovations and best practice in medical publishing and communications.
In an article in Current Medical Research & Opinion, three leading medical publishing organisations provide guidance on dealing with predatory publishers.
Depositing preprints on bioRxiv results in advantages in terms of citations and Altmetrics, according to recently published findings.
Simon Stones gives his view on the practical steps that patients, publishers and the pharmaceutical industry can take to boost patient involvement in research.
Authors of an article in Nature believe it is time to move beyond the journal impact factor and discuss what next-generation metrics should look like.
Open source software is often used in science but is left uncited in many publications: researchers urge authors to make a change.
A recent blog for The Scholarly Kitchen explores the pros and cons of a searchable predatory journal directory.
As demand for transparency increases, many journals are adopting open peer review: learn more about best-practice guidelines for implementing such systems.
An article in the MAP newsletter examines how plain language summaries are key in making peer-reviewed biomedical research accessible to all.
How do predatory journals get indexed in PubMed and how big a problem is it?
A recent article from Nature news delves into clinical trial reporting following evidence showing that some universities are failing to meet EU regulations.